Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C M Beasley

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
The Australian and New Zealand Journal of Psychiatry|April 10, 1999
Response to letter of Professor Tim LambertC M Beasley
The Journal of Clinical Psychiatry|February 1, 1994
Fluoxetine-dopaminergic interaction dataC M Beasley
BMJ (Clinical Research Ed.)|November 19, 1991
Fluoxetine and suicideC M Beasley
International Clinical Psychopharmacology|January 1, 1993
Fluoxetine: activating and sedating effectsC M Beasley, J H Potvin
Journal of the American Academy of Child and Adolescent Psychiatry|September 11, 1991
Fluoxetine mechanism of actionR W Fuller, C M Beasley
The Journal of Clinical Psychiatry|March 10, 2001
Cardiac safety parameters of olanzapine: comparison with other atypical and typical antipsychoticsJ Czekalla, S Kollack-Walker, C M Beasley
Biological Psychiatry|August 1, 1988
TSH response to TRH and haloperidol response latency in psychosesC M Beasley, M Magnusson, D L Garver
International Clinical Psychopharmacology|January 1, 1993
Fluoxetine not associated with increased aggression in controlled clinical trialsJ H Heiligenstein, C M Beasley, J H Potvin
The Journal of Clinical Psychiatry|January 1, 1997
Efficacy of olanzapine: an overview of pivotal clinical trialsC M Beasley, G D Tollefson, P V Tran
Psychopharmacology|January 1, 1992
Fluoxetine: a review of receptor and functional effects and their clinical implicationsC M Beasley, D N Masica, J H Potvin
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
The Australian and New Zealand Journal of Psychiatry|April 10, 1999
Response to letter of Professor Tim LambertC M Beasley
The Journal of Clinical Psychiatry|February 1, 1994
Fluoxetine-dopaminergic interaction dataC M Beasley
BMJ (Clinical Research Ed.)|November 19, 1991
Fluoxetine and suicideC M Beasley
International Clinical Psychopharmacology|January 1, 1993
Fluoxetine: activating and sedating effectsC M Beasley, J H Potvin
Journal of the American Academy of Child and Adolescent Psychiatry|September 11, 1991
Fluoxetine mechanism of actionR W Fuller, C M Beasley
The Journal of Clinical Psychiatry|March 10, 2001
Cardiac safety parameters of olanzapine: comparison with other atypical and typical antipsychoticsJ Czekalla, S Kollack-Walker, C M Beasley
Biological Psychiatry|August 1, 1988
TSH response to TRH and haloperidol response latency in psychosesC M Beasley, M Magnusson, D L Garver
International Clinical Psychopharmacology|January 1, 1993
Fluoxetine not associated with increased aggression in controlled clinical trialsJ H Heiligenstein, C M Beasley, J H Potvin
The Journal of Clinical Psychiatry|January 1, 1997
Efficacy of olanzapine: an overview of pivotal clinical trialsC M Beasley, G D Tollefson, P V Tran
Psychopharmacology|January 1, 1992
Fluoxetine: a review of receptor and functional effects and their clinical implicationsC M Beasley, D N Masica, J H Potvin
Pageof 6